MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-04-2026
Sensus Healthcare Retained Earnings 2011-2026 | SRTS
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings Sensus Healthcare
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.72 M | 13.4 M | 6.79 M | 6.3 M | -17.9 M | -22.1 M | -15.2 M | -13.5 M | -11.5 M | -7.79 M | -7.45 M | -7.21 M | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 13.4 M | -22.1 M | -5.87 M |
Quarterly Retained Earnings Sensus Healthcare
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.88 M | 9.82 M | 10.9 M | 13.4 M | 11.9 M | 10.7 M | - | 6.79 M | 2.58 M | 4.03 M | 4.41 M | 6.3 M | 3.47 M | 1.64 M | -1.88 M | -17.9 M | -23.3 M | -23.5 M | -23.2 M | -22.1 M | -22.1 M | -22.1 M | -22.1 M | -15.2 M | -15.2 M | -15.2 M | -15.2 M | -13.5 M | -13.5 M | -13.5 M | -13.5 M | -11.5 M | -11.5 M | -11.5 M | -11.5 M | -7.79 M | -7.79 M | -7.79 M | -7.79 M | -7.45 M | -7.45 M | -7.45 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 13.4 M | -23.5 M | -7.26 M |
Retained Earnings of other stocks in the Medical devices industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aethlon Medical
AEMD
|
-168 M | $ 2.2 | -0.45 % | $ 3.43 M |  USA |
 |
Acutus Medical
AFIB
|
-600 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
-15.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
AdaptHealth Corp.
AHCO
|
-633 M | $ 10.55 | 0.91 % | $ 1.43 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-533 M | - | - | $ 1.77 B | USA |
 |
Alphatec Holdings
ATEC
|
-1.42 B | $ 12.94 | -0.84 % | $ 1.94 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-185 M | - | -5.86 % | $ 30.6 M | USA |
 |
Avinger
AVGR
|
-421 M | - | -20.74 % | $ 369 K | USA |
 |
Cognyte Software Ltd.
CGNT
|
-157 M | $ 8.29 | -0.84 % | $ 595 M |  Israel |
 |
Aziyo Biologics
AZYO
|
-176 M | - | 1.37 % | $ 20.5 M | USA |
 |
ClearPoint Neuro
CLPT
|
-217 M | $ 9.69 | -13.17 % | $ 274 M | USA |
 |
Butterfly Network
BFLY
|
-802 M | $ 4.05 | -4.93 % | $ 857 M | USA |
 |
BIOLASE
BIOL
|
-317 M | - | -13.19 % | $ 166 K | USA |
 |
Conformis
CFMS
|
-581 M | - | - | $ 16.4 M | USA |
 |
Boston Scientific Corporation
BSX
|
5.57 B | $ 70.93 | -0.45 % | $ 105 B | USA |
 |
Cytosorbents Corporation
CTSO
|
-304 M | $ 0.66 | -2.96 % | $ 35.9 M | USA |
 |
Apollo Endosurgery
APEN
|
-337 M | - | - | $ 475 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-82.6 M | $ 3.96 | -2.28 % | $ 148 M |  France |
 |
CONMED Corporation
CNMD
|
589 M | $ 37.07 | -0.3 % | $ 1.15 B | USA |
 |
Establishment Labs Holdings
ESTA
|
-496 M | $ 65.5 | 0.75 % | $ 1.94 B |  Costa-rica |
 |
CryoLife, Inc.
CRY
|
20 M | - | -4.14 % | $ 702 M | USA |
 |
Cutera
CUTR
|
-303 M | - | -10.19 % | $ 1.99 M | USA |
 |
Dynatronics Corporation
DYNT
|
-40.5 M | - | 14.99 % | $ 929 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
-374 M | - | - | $ 3.31 B | USA |
 |
Soliton, Inc.
SOLY
|
-70.6 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-56.2 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-119 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
-39.3 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-395 M | - | - | $ 111 M |  Canada |
 |
FONAR Corporation
FONR
|
-33.6 M | $ 18.45 | -0.03 % | $ 121 M | USA |
 |
Intersect ENT, Inc.
XENT
|
-303 M | - | - | $ 955 M | USA |
 |
GBS
GBS
|
-62.5 M | - | -0.57 % | $ 7.12 M | USA |
 |
Abbott Laboratories
ABT
|
49.8 B | $ 108.88 | -1.69 % | $ 190 B | USA |
 |
InMode Ltd.
INMD
|
969 M | $ 13.57 | -0.59 % | $ 877 M | Israel |
 |
Delcath Systems
DCTH
|
-529 M | $ 9.46 | -2.87 % | $ 339 M | USA |
 |
IRIDEX Corporation
IRIX
|
-79 M | $ 1.33 | - | $ 21.5 M | USA |
 |
Bio-Rad Laboratories
BIO
|
7.42 B | $ 269.22 | -0.06 % | $ 7.6 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-275 M | $ 16.83 | -2.21 % | $ 395 M | USA |
 |
Helius Medical Technologies
HSDT
|
-160 M | $ 2.07 | -4.61 % | $ 1.26 M | USA |
 |
AxoGen
AXGN
|
-307 M | $ 30.96 | -5.48 % | $ 1.43 B | USA |
 |
Align Technology
ALGN
|
2.48 B | $ 172.07 | -2.3 % | $ 12.9 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
940 M | $ 8.89 | -2.31 % | $ 685 M | USA |
 |
Bruker Corporation
BRKR
|
2.41 B | $ 34.23 | 1.45 % | $ 5.1 K | USA |
 |
BioSig Technologies
BSGM
|
-255 M | - | 37.08 % | $ 85.7 M | USA |
 |
Apyx Medical Corporation
APYX
|
-89.1 M | $ 3.73 | -0.27 % | $ 153 M | USA |
 |
Second Sight Medical Products
EYES
|
-122 M | - | -0.97 % | $ 54.4 M | USA |
 |
Accuray Incorporated
ARAY
|
-519 M | $ 0.4 | 1.81 % | $ 41.1 M | USA |
 |
IRadimed Corporation
IRMD
|
64.2 M | $ 101.27 | -1.49 % | $ 1.29 B | USA |